DCX and Stroke: We found that rIL-6 treatment had no significant effects on the number of BrdU+/DCX+ cells in the ischemic striatum of CD25-treated mice at 28 dpi (P > 0.05; Figure 6B,C), indicating an essential role of Tregs in IL-6-mediated post-stroke angioneurogenesis.